Molecular predictors of response to selinexor in advanced unresectable de-differentiated liposarcoma (DDLS).

11509Background: Patients (pts) with recurrent inoperative DDLS have a poor prognosis and limited treatment options. Selinexor is an oral, selective inhibitor of nuclear export (SINE) compound appr...